WallStreetZenWallStreetZen

NASDAQ: TGTX
Tg Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TGTX

Based on 5 analysts offering 12 month price targets for Tg Therapeutics Inc

Min Forecast
$39.00+33.61%
Avg Forecast
$49.80+70.61%
Max Forecast
$60.00+105.55%

Should I buy or sell TGTX stock?

Based on 5 analysts offering ratings for Tg Therapeutics Inc.

Strong Buy
Strong Buy
3 analysts 60%
Buy
1 analysts 20%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TGTX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates TGTX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their TGTX stock forecasts and price targets.

TGTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-02
lockedlocked$00.00+00.00%2026-01-15
lockedlocked$00.00+00.00%2025-11-03
lockedlocked$00.00+00.00%2025-10-06
lockedlocked$00.00+00.00%2025-09-17Find Out Why

1 of 1

Forecast return on equity

Is TGTX forecast to generate an efficient return?

Company
92.62%
Industry
67.7%
Market
180.41%
TGTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TGTX forecast to generate an efficient return on assets?

Company
56.45%
Industry
31.6%
TGTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TGTX earnings per share forecast

What is TGTX's earnings per share in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$1.61-48.14%
Avg 2 year Forecast
$2.33-24.76%
Avg 3 year Forecast
$3.11+0.27%
TGTX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

TGTX revenue forecast

What is TGTX's revenue in the next 3 years based on estimates from 10 analysts?

Avg 1 year Forecast
$916.7M+48.75%
Avg 2 year Forecast
$1.1B+85.95%
Avg 3 year Forecast
$1.5B+144.69%
TGTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TGTX earnings growth forecast

How is TGTX forecast to perform vs Biotechnology companies and vs the US market?

Company
-0.03%
Industry
11.96%
Market
36.32%
TGTX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
TGTX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
TGTX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

TGTX revenue growth forecast

How is TGTX forecast to perform vs Biotechnology companies and vs the US market?

Company
33.89%
Industry
38.19%
Market
13.55%
TGTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TGTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TGTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TGTX$29.27$49.80+70.14%Strong Buy
FOLD$14.34$14.57+1.61%Buy
ERAS$15.47$10.00-35.36%Strong Buy
APGE$73.05$103.71+41.98%Strong Buy
PTCT$62.82$80.50+28.14%Buy
View Top Biotech Stocks

Tg Therapeutics Stock Forecast FAQ

Is Tg Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: TGTX) stock is to Strong Buy TGTX stock.

Out of 5 analysts, 3 (60%) are recommending TGTX as a Strong Buy, 1 (20%) are recommending TGTX as a Buy, 1 (20%) are recommending TGTX as a Hold, 0 (0%) are recommending TGTX as a Sell, and 0 (0%) are recommending TGTX as a Strong Sell.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.

What is TGTX's earnings growth forecast for 2026-2028?

(NASDAQ: TGTX) Tg Therapeutics's forecast annual earnings growth rate of -0.03% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.44%.

Tg Therapeutics's earnings in 2026 is $447,179,000.On average, 10 Wall Street analysts forecast TGTX's earnings for 2026 to be $256,746,778, with the lowest TGTX earnings forecast at $198,748,003, and the highest TGTX earnings forecast at $321,931,524. On average, 8 Wall Street analysts forecast TGTX's earnings for 2027 to be $372,456,888, with the lowest TGTX earnings forecast at $287,949,863, and the highest TGTX earnings forecast at $534,875,813.

In 2028, TGTX is forecast to generate $496,390,944 in earnings, with the lowest earnings forecast at $341,157,990 and the highest earnings forecast at $704,225,209.

What is TGTX's revenue growth forecast for 2026-2028?

(NASDAQ: TGTX) Tg Therapeutics's forecast annual revenue growth rate of 33.89% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.4%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.44%.

Tg Therapeutics's revenue in 2026 is $616,287,000.On average, 10 Wall Street analysts forecast TGTX's revenue for 2026 to be $146,389,418,040, with the lowest TGTX revenue forecast at $137,010,926,765, and the highest TGTX revenue forecast at $153,929,897,489. On average, 8 Wall Street analysts forecast TGTX's revenue for 2027 to be $183,002,741,376, with the lowest TGTX revenue forecast at $147,722,814,978, and the highest TGTX revenue forecast at $207,115,668,032.

In 2028, TGTX is forecast to generate $240,809,890,048 in revenue, with the lowest revenue forecast at $212,545,068,736 and the highest revenue forecast at $270,671,593,920.

What is TGTX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: TGTX) forecast ROA is 56.45%, which is higher than the forecast US Biotechnology industry average of 32.04%.

What is TGTX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year TGTX price target, the average TGTX price target is $49.80, with the highest TGTX stock price forecast at $60.00 and the lowest TGTX stock price forecast at $39.00.

On average, Wall Street analysts predict that Tg Therapeutics's share price could reach $49.80 by Feb 2, 2027. The average Tg Therapeutics stock price prediction forecasts a potential upside of 70.14% from the current TGTX share price of $29.27.

What is TGTX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: TGTX) Tg Therapeutics's current Earnings Per Share (EPS) is $3.10. On average, analysts forecast that TGTX's EPS will be $1.61 for 2026, with the lowest EPS forecast at $1.24, and the highest EPS forecast at $2.02. On average, analysts forecast that TGTX's EPS will be $2.33 for 2027, with the lowest EPS forecast at $1.80, and the highest EPS forecast at $3.35. In 2028, TGTX's EPS is forecast to hit $3.11 (min: $2.14, max: $4.41).

What is TGTX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: TGTX) forecast ROE is 92.62%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.